{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:02:52Z","timestamp":1791025372040,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00125-012-2819-3","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T01:45:26Z","timestamp":1359510326000},"page":"714-723","source":"Crossref","is-referenced-by-count":110,"title":["A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance"],"prefix":"10.1007","volume":"56","author":[{"given":"A. B.","family":"Goldfine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R.","family":"Conlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Koska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Permana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schwenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Shoelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. D.","family":"Reaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"key":"2819_CR1","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Investig 116:1793\u20131801","journal-title":"J Clin Investig"},{"key":"2819_CR2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860\u2013867","journal-title":"Nature"},{"key":"2819_CR3","first-page":"337","volume":"13","author":"W Ebstein","year":"1876","unstructured":"Ebstein W (1876) Zur therapie des Diabetes mellitus, insbesondere uber die Anwendung des salicylsauren Natron bei demselben. Berliner Klinische Wochenschrift 13:337\u2013340 [article in German]","journal-title":"Berliner Klinische Wochenschrift"},{"key":"2819_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1962.03050140067017c","volume":"180","author":"SG Gilgore","year":"1962","unstructured":"Gilgore SG, Rupp JJ (1962) The long-term response of diabetes mellitus to salicylate therapy: report of a case. JAMA 180:65\u201366","journal-title":"JAMA"},{"key":"2819_CR5","first-page":"418","volume":"8","author":"A Hecht","year":"1959","unstructured":"Hecht A, Goldner MG (1959) Reappraisal of the hypoglycemic action of acetylsalicylate. Metabolism 8:418\u2013428","journal-title":"Metabolism"},{"key":"2819_CR6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.2.5053.1071","volume":"2","author":"J Reid","year":"1957","unstructured":"Reid J, Macdougall AI, Andrews MM (1957) Aspirin and diabetes mellitus. Br Med J 2:1071\u20131074","journal-title":"Br Med J"},{"key":"2819_CR7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/bmj.1.2100.760","volume":"1","author":"RT Williamson","year":"1901","unstructured":"Williamson RT (1901) On the treatment of glycosuria and diabetes mellitus with sodium salicylate. Br Med J 1:760\u2013762","journal-title":"Br Med J"},{"key":"2819_CR8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","volume":"265","author":"E Kopp","year":"1994","unstructured":"Kopp E, Ghosh S (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956\u2013959","journal-title":"Science"},{"key":"2819_CR9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396:77\u201380","journal-title":"Nature"},{"key":"2819_CR10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","volume":"293","author":"M Yuan","year":"2001","unstructured":"Yuan M, Konstantopoulos N, Lee J et al (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673\u20131677","journal-title":"Science"},{"key":"2819_CR11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","volume":"11","author":"MC Arkan","year":"2005","unstructured":"Arkan MC, Hevener AL, Greten FR et al (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191\u2013198","journal-title":"Nat Med"},{"key":"2819_CR12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","volume":"108","author":"JK Kim","year":"2001","unstructured":"Kim JK, Kim YJ, Fillmore JJ et al (2001) Prevention of fat-induced insulin resistance by salicylate. J Clin Investig 108:437\u2013446","journal-title":"J Clin Investig"},{"key":"2819_CR13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai D, Yuan M, Frantz DF et al (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183\u2013190","journal-title":"Nat Med"},{"key":"2819_CR14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","volume":"152","author":"AB Goldfine","year":"2010","unstructured":"Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE (2010) The effects of salsalate on glycemic control in patients with type 2 diabetes. Ann Intern Med 152:346\u2013357","journal-title":"Ann Intern Med"},{"key":"2819_CR15","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","volume":"109","author":"RS Hundal","year":"2002","unstructured":"Hundal RS, Petersen KF, Mayerson AB et al (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Investig 109:1321\u20131326","journal-title":"J Clin Investig"},{"key":"2819_CR16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1752-8062.2008.00026.x","volume":"1","author":"AB Goldfine","year":"2008","unstructured":"Goldfine AB, Silver R, Aldhahi W et al (2008) Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci 1:36\u201343","journal-title":"Clin Transl Sci"},{"key":"2819_CR17","doi-asserted-by":"crossref","unstructured":"Faghihimani E, Aminorroaya A, Rezvanian H, Adibi P, Ismail-Beigi F, Amini M (2011) Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes. Acta Diabetol. doi: 10.1007\/s00592-011-0329-2","DOI":"10.1007\/s00592-011-0329-2"},{"key":"2819_CR18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","volume":"31","author":"A Fleischman","year":"2008","unstructured":"Fleischman A, Shoelson SE, Bernier R, Goldfine AB (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31:289\u2013294","journal-title":"Diabetes Care"},{"key":"2819_CR19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00125-008-1239-x","volume":"52","author":"J Koska","year":"2009","unstructured":"Koska J, Ortega E, Bunt JC et al (2009) The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia 52:385\u2013393","journal-title":"Diabetologia"},{"key":"2819_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF00291974","volume":"28","author":"PR Bratusch-Marrain","year":"1985","unstructured":"Bratusch-Marrain PR, Vierhapper H, Komjati M, Waldhausl WK (1985) Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man. Diabetologia 28:671\u2013676","journal-title":"Diabetologia"},{"key":"2819_CR21","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1210\/jc.2007-1212","volume":"93","author":"J-M Fernandez-Real","year":"2008","unstructured":"Fernandez-Real J-M, Lopez-Bermejo A, Ropero A-B et al (2008) Salicylates increase insulin secretion in healthy obese subjects. J Clin Endocrinol Metab 93:2523\u20132530","journal-title":"J Clin Endocrinol Metab"},{"key":"2819_CR22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jcem-57-6-1102","volume":"57","author":"WP Newman","year":"1983","unstructured":"Newman WP, Brodows RG (1983) Aspirin causes tissue insensitivity to insulin in normal man. J Clin Endocrinol Metab 57:1102\u20131106","journal-title":"J Clin Endocrinol Metab"},{"key":"2819_CR23","first-page":"1","volume":"11","author":"E Faghihimani","year":"2012","unstructured":"Faghihimani E, Aminorroaya A, Rezvanian H, Adibi P, Ismail-Beigi F, Amini M (2012) Salsalate reduces insulin resistance and plasma glucose level in persons with prediabetes. Endocr Pract 11:1\u201317","journal-title":"Endocr Pract"},{"key":"2819_CR24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jcem-61-1-160","volume":"61","author":"D Giugliano","year":"1985","unstructured":"Giugliano D, Ceriello A, Saccomanno F, Quatraro A, Paolisso G, D'Onofrio F (1985) Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 61:160\u2013166","journal-title":"J Clin Endocrinol Metab"},{"key":"2819_CR25","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214\u2013E223","journal-title":"Am J Physiol"},{"key":"2819_CR26","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1210\/jc.82.6.1834","volume":"82","author":"CNO Jones","year":"1997","unstructured":"Jones CNO, Pei D, Staris P, Polonsky KS, Chen YD-I, Reaven GM (1997) Alterations in the glucose-stimulated insulin secretory dose\u2013response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab 82:1834\u20131838","journal-title":"J Clin Endocrinol Metab"},{"key":"2819_CR27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/dc09-1961","volume":"33","author":"J Koska","year":"2010","unstructured":"Koska J, Schwartz EA, Mullin MP, Schwenke DC, Reaven PD (2010) Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recent-onset type 2 diabetes. Diabetes Care 33:1028\u20131030","journal-title":"Diabetes Care"},{"key":"2819_CR28","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.jacc.2004.08.062","volume":"44","author":"PO Bonetti","year":"2004","unstructured":"Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A (2004) Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44:2137\u20132141","journal-title":"J Am Coll Cardiol"},{"key":"2819_CR29","doi-asserted-by":"crossref","first-page":"24944","DOI":"10.1074\/jbc.M300423200","volume":"278","author":"Z Gao","year":"2003","unstructured":"Gao Z, Zuberi A, Quon MJ, Dong Z, Ye J (2003) Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem 278:24944\u201324950","journal-title":"J Biol Chem"},{"key":"2819_CR30","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1046\/j.1432-1033.2003.03740.x","volume":"270","author":"K Ishihara","year":"2003","unstructured":"Ishihara K, Horiguchi K, Yamagishi N, Hatayama T (2003) Identification of sodium salicylate as an hsp inducer using a simple screening system for stress response modulators in mammalian cells. Eur J Biochem 270:3461\u20133468","journal-title":"Eur J Biochem"},{"key":"2819_CR31","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.1215327","volume":"336","author":"SA Hawley","year":"2012","unstructured":"Hawley SA, Fullerton MD, Ross FA et al (2012) The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336:918\u2013922","journal-title":"Science"},{"key":"2819_CR32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/201192a0","volume":"201","author":"WJ Hines","year":"1964","unstructured":"Hines WJ, Smith MJ (1964) Inhibition of dehydrogenases by salicylate. Nature 201:192","journal-title":"Nature"},{"key":"2819_CR33","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.1546322","volume":"255","author":"DA Jurivich","year":"1992","unstructured":"Jurivich DA, Sistonen L, Kroes RA, Morimoto RI (1992) Effect of sodium salicylate on the human heat shock response. Science 255:1243\u20131245","journal-title":"Science"},{"key":"2819_CR34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/db11-0931","volume":"61","author":"M Nixon","year":"2012","unstructured":"Nixon M, Wake DJ, Livingstone DE et al (2012) Salicylate downregulates 11beta-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization. Diabetes 61:790\u2013796","journal-title":"Diabetes"},{"key":"2819_CR35","doi-asserted-by":"crossref","first-page":"E1099","DOI":"10.1152\/ajpendo.00185.2011","volume":"301","author":"JA Diepen van","year":"2011","unstructured":"van Diepen JA, Vroegrijk IO, Berbee JF et al (2011) Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet. Am J Physiol Endocrinol Metab 301:E1099\u2013E1107","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2819_CR36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439\u2013451","journal-title":"Endocr Rev"},{"key":"2819_CR37","first-page":"353","volume":"90","author":"RP Robertson","year":"1977","unstructured":"Robertson RP, Chen M (1977) Modulation of insulin secretion in normal and diabetic humans by prostaglandin E and sodium salicylate. Trans Assoc Am Phys 90:353\u2013365","journal-title":"Trans Assoc Am Phys"},{"key":"2819_CR38","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.2337\/diabetes.51.6.1772","volume":"51","author":"PO Tran","year":"2002","unstructured":"Tran PO, Gleason CE, Robertson RP (2002) Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function. Diabetes 51:1772\u20131778","journal-title":"Diabetes"},{"key":"2819_CR39","first-page":"279","volume":"8","author":"D Giugliano","year":"1982","unstructured":"Giugliano D, Sacca L, Scognamiglio G, Ungaro B, Torella R (1982) Influence of acetylsalicylic acid on glucose turnover in normal man. Diabetes Metabol 8:279\u2013282","journal-title":"Diabetes Metabol"},{"key":"2819_CR40","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1210\/jc.2005-1889","volume":"91","author":"M Mohlig","year":"2006","unstructured":"Mohlig M, Freudenberg M, Bobbert T et al (2006) Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men. J Clin Endocrinol Metab 91:964\u2013967","journal-title":"J Clin Endocrinol Metab"},{"key":"2819_CR41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jc.2006-2491","volume":"93","author":"SN Crabben van der","year":"2008","unstructured":"van der Crabben SN, Allick G, Ackermans MT, Endert E, Romijn JA, Sauerwein HP (2008) Prolonged fasting induces peripheral insulin resistance, which is not ameliorated by high-dose salicylate. J Clin Endocrinol Metab 93:638\u2013641","journal-title":"J Clin Endocrinol Metab"},{"key":"2819_CR42","doi-asserted-by":"crossref","first-page":"E1205","DOI":"10.1152\/ajpendo.00313.2009","volume":"297","author":"C Xiao","year":"2009","unstructured":"Xiao C, Giacca A, Lewis GF (2009) The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and beta-cell dysfunction in overweight and obese nondiabetic men. Am J Physiol Endocrinol Metab 297:E1205\u2013E1211","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2819_CR43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1172\/JCI113069","volume":"80","author":"H Yki-Jarvinen","year":"1987","unstructured":"Yki-Jarvinen H, Mott D, Young AA, Stone K, Bogardus C (1987) Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Investig 80:95\u2013100","journal-title":"J Clin Investig"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2819-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-012-2819-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2819-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:49:46Z","timestamp":1558597786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-012-2819-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2819"],"URL":"https:\/\/doi.org\/10.1007\/s00125-012-2819-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}